Clinical Trial

Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TRT-448 in Healthy Adult Subjects

Name: Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TRT-448 in Healthy Adult Subjects — clinical trial record (NCT07745751)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TRT-448-101

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TRT-448 in Healthy Adult Subjects

Trial Details

NCT Number	NCT07745751
Lead Sponsor	Trotana, Inc.
Conditions	Safety and Tolerability in Healthy Volunteers
Enrollment	144 participants
Start Date	2026-08-30
Primary Completion	2027-04-01 (estimated)
Study Completion	2027-05-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-06